aclaris

March 6 (Reuters) - Aclaris Therapeutics Inc said on Monday its experimental drug failed to meet the main goal of a mid-stage study for the treatment of a type of known skin disorder as Hidradenitis Suppurativa. (Reporting by Raghav…

March 6 (Reuters) - Aclaris Therapeutics Inc said on Monday its experimental drug failed to meet the main goal of a mid-stage study to treat a painful skin disorder, sending the -its shares fall more than 36% in pre-market trading.…